Navigation Links
Royalty Pharma Announces Proposal To Acquire Elan
Date:2/25/2013

ings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for either Royalty Pharma or Elan as appropriate.

APPENDIX I: DefinitionsThe following definitions apply throughout this announcement unless the context otherwise requires:"Act"

the Companies Act 1963 of Ireland (as amended);"Alkermes Shares"

the 7.75 million ordinary shares of Alkermes plc sold by Elan Science Three Limited on February 6, 2013;"Biogen"

Biogen Idec Inc.; "Board of Elan"

the board of directors of Elan at the date of this announcement;"Broker Median Price Target"

the median of the price targets given by the brokers named in the Sources and Bases section that have published price targets following the announcement of the Tysabri Transaction on February 6, 2013;"Broker Projected Earnings Per Share"

the median of earnings per share forecasts made by the brokers named in the Sources and Bases section that have published revised earnings per share forecasts following the announcement of the Tysabri Transaction on February 6, 2013; "Broker Projected EBITDA"

the median of EBITDA forecasts made by the brokers named in the Sources and Bases section that have published revised EBITDA forecasts following the announcement of the Tysabri Transaction on February 6, 2013;"Current Enterprise Value"

the enterprise value of Elan as at February 15, 2013, calculated by Royalty Pharma in accordance with Appendix II;"Elan" or "the Company"

Elan Corporation plc;"Elan ADS"

Elan American Depository Shares, each representing one (1)Elan Share;"Elan Group"

Elan and each of its subsidiaries and subsidiary undertakings;"Elan Shareholders"

the registered holders of Elan Shares and the holders of Elan ADS; "Elan Shareholder" means any of such holders;"Elan Shares"

the ordinary shares of €0.05 each in the capital of Elan and "Elan Share" means an
'/>"/>

SOURCE Royalty Pharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Royalty Rates Take Center Stage in Biopharma Dealmaking
2. Reckitt Benckiser Pharmaceuticals Inc. Receives FDA Response to Citizens Petition
3. Health Outcomes Liaisons (HOLs) Serve as Key Bridge between Pharmaceutical Sector and Managed Care Groups
4. Keryx Biopharmaceuticals to Present at the Citigroup 2013 Global Healthcare Conference
5. State Food and Drug Administration Grants Approval to Sihuan Pharmaceutical for Clinical Trial of Innovative Drug -- Pinoxacin Hydrochloride
6. Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2012
7. Pharmaceutical Leader Boehringer Ingelheim Selects Republica as Cross-Cultural Marketing Agency
8. Tomorrows Outlook in Todays Market - Research Report on Toyota Motor Corporation, Honda Motor Co., Ltd., Yahoo! Inc., AOL, Inc. and Aegerion Pharmaceuticals, Inc.
9. Promise and Problems Signal Mixed Year Ahead for Biopharmaceutical Industry, Says Pharmaceutical Executive Magazine
10. Webcast Alert: Isis Pharmaceuticals 2012 Financial Results and Highlights Conference Call
11. Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2012 Fourth Quarter And Full Year Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... 2015 Akcea Therapeutics, a wholly-owned subsidiary ... announced today that the U.S. Food and Drug ... (ISIS-APOCIII Rx ) for the treatment of patients ... rare genetic disease characterized by extremely high triglyceride ... 2 study published in the NEJM in December ...
(Date:7/6/2015)... 6, 2015 /PRNewswire/ -- China Nepstar Chain Drugstore Ltd. (NYSE: ... retail drugstore chain in China ... announced that its board of directors has received a ... Simin Zhang , chairman of the board of ... Ltd., an investment vehicle wholly owned by Mr. Zhang(" ...
(Date:7/4/2015)... Spanje, July 4, 2015 ... aan eerstelijns chemotherapie voor patiënten met niet-resectabele ... verlengt de progressievrije overleving in dat orgaan. ... colorectale kanker (mCRC) die alleen binnen de ... in progressievrije overleving (PFS) in de lever ...
Breaking Medicine Technology:Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 2Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 3Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 5Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 6China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 2China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 3China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 4China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 5China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 6Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 2Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 3Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 4Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 5
... Correlated With Clinical Response, CHICAGO, May ... today highlighted the potential of its,investigational MAGE-A3 ... studies evaluating highly targeted immunotherapy,as a treatment ... cancer,(NSCLC). These data were presented at the ...
... in preventing ... Contrast-Induced Nephropathy, FRANKLIN, Mass., May 30 ... on innovative cardiac and vascular medical,device-based technologies, announced today that ... Milan, Italy has,approved the planned randomized clinical trial to evaluate ...
Cached Medicine Technology:New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma 2New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma 3New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma 4New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma 5New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma 6New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma 7PLC Systems Announces Approval of First European Study to Evaluate RenalGuard(TM) 2PLC Systems Announces Approval of First European Study to Evaluate RenalGuard(TM) 3PLC Systems Announces Approval of First European Study to Evaluate RenalGuard(TM) 4PLC Systems Announces Approval of First European Study to Evaluate RenalGuard(TM) 5
(Date:7/4/2015)... (PRWEB) , ... July 04, 2015 , ... ... the solar industry’s leading recognition of technical sales expertise from the North American ... Technical Sales ProfessionalTM. NABCEP is the most highly respected and well established national ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... ... for enrollment on July 2nd creating a buzz of media attention. In an ... published online by HonestyFirstReviews.com's Tiffany Hendricks. , "These days many people are feeling ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... speaker lineup for its 2015 Annual Conference , the premiere continuing ... at the Renaissance Orlando at SeaWorld in Orlando, Florida. Speakers include the ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... Renowned ... the dates for the 2016 Dallas Rhinoplasty Symposium . To be held from ... the meeting will be held at the Westin Galleria Dallas. , Designed to take ...
(Date:7/3/2015)... ... 03, 2015 , ... B. E. Smith, the only full-service ... a national chief nursing officer recruitment for Jane Phillips Medical Center ... industry, B. E. Smith has recently placed more than 1,000 healthcare executives into ...
Breaking Medicine News(10 mins):Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 2Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 3Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3
... molecule sops up bad lipoproteins, researchers say , , ... high-density lipoprotein (HDL) -- the "good" cholesterol -- ... levels and the deadly cardiovascular disease it can ... University researchers, is close in size to natural ...
... PARK, N.J., Jan. 30 Americans resolving to eat ... ahead are also likely to look for ways to ... costs while increasing nutritional intake? Dr. Praeger,s Sensible Foods, ... simple solutions to encourage Americans to get on the ...
... Traumatic brain injury (TBI) has been identified as ... Afghanistan. , TBI is known to cause ... in conjunction with post-traumatic stress disorder (PTSD), depression, anxiety ... veterans have been diagnosed with TBI, based on statistics ...
... Jan. 30 Stryker Corporation (NYSE: SYK ... Meeting on Wednesday, May 20, 2009, at 8:00 a.m. ... President and Chief Executive Officer, will host the meeting ... units.A simultaneous webcast of the meeting will be available ...
... Tenn., Jan. 30 Smith & Nephew, Inc.,(NYSE: ... that its Orthopaedics Reconstruction,Division has entered into a ... Foundation (OREF). , Under ... third-party,administrator of grants, OREF will assist Smith & ...
... Fla., Jan. 30 LifeSync Corporation, a wireless ECG ... for the sale of the LifeSync(R) Wireless ECG System ... Chain Systems effective February 1, 2009. MedAssets Supply Chain ... supply chain services in U.S., serving more than 125 ...
Cached Medicine News:Health News:Synthetic HDL Could Fight Heart Disease 2Health News:Lower Your Grocery Bill, Improve Health In 2009: Top Tips From Dr. Praeger's Sensible Foods 2Health News:Lower Your Grocery Bill, Improve Health In 2009: Top Tips From Dr. Praeger's Sensible Foods 3Health News:Study of Iraq veterans' traumatic brain injuries to be conducted by UB researchers 2Health News:Stryker to Host Analyst Meeting 2Health News:Smith & Nephew Announces Agreement with the OREF Regarding Grants to Support Research and Education in Orthopaedics 2Health News:Smith & Nephew Announces Agreement with the OREF Regarding Grants to Support Research and Education in Orthopaedics 3Health News:Smith & Nephew Announces Agreement with the OREF Regarding Grants to Support Research and Education in Orthopaedics 4Health News:LifeSync Corporation Awarded Multiyear Agreement with MedAssets Supply Chain Systems for the LifeSync(R) Wireless ECG System 2
... CT MIYABI system is a ... CT scanner on rails (Sliding ... angiography unit. Both systems use ... which can be switched between ...
Spring Type with lock. Titanium....
... ease of the World's First Hand-Held Autorefractor/Keratometer. ... accuracy, reliability and performance Share the Retinomax ... no wires to limit, you can use ... range and advanced measurement modes. Readings ...
Introducing the Guidant HEARTSTRING Proximal Seal System. A surgically intuitive system that meets the challenge of clampless hemostasis with a design that is elegant in its simplicity and profound i...
Medicine Products: